Functional genomics reveals the mechanism of hypoxic adaptation in nontuberculous mycobacteria
Construction of knockout mutants in Mycobacterium intracellulare ATCC13950 strain using a thermosensitive plasmid containing negative selection marker rpsL.
Tateishi Y, Nishiyama A, Ozeki Y, Matsumoto S.
Microbiol Immunol. 2024 Oct;68(10):339-347.
Exploring Indonesian actinomycete extracts for anti-tubercular compounds: Integrating inhibition assessment, genomic analysis, and prediction of its target by molecular docking.
Nurkanto A, Masrukhin, Erdian Tampubolon JC, Ewaldo MF, Putri AL, Ratnakomala S, Setiawan R, Fathoni A, Palupi KD, Rahmawati Y, Waluyo D, Prabandari EE, Pujiyanto S, Sumii Y, Agusta A, Shibata N, Matsumoto S, Nozaki T.
Heliyon. 2024 Aug 4;10(15):e35648.
Scientific Reports, 2024 Apr 21;14(1):9141. doi: 10.1038/s41598-024-58836-8.
Frontiers in Immunology, Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1330796
Kishino M, Hida A, Chadeka EA, Inoue M, Osada-Oka M, Matsumoto S, Njenga SM, Hamano S, Nagi S.
Trop Med Health. 2024 Jan 17;52(1):12. doi: 10.1186/s41182-023-00566-0.
Microbiol Immunol. 2024 Jan 31. doi: 10.1111/1348-0421.13116.
Dynamic action of an intrinsically disordered protein in DNA compaction that induces mycobacterial dormancy.
Akihito Nishiyama, Masahiro Shimizu, Tomoyuki Narita, Noriyuki Kodera, Yuriko Ozeki, Akira Yokoyama, Kouta Mayanagi, Takehiro
Yamaguchi, Mariko Hakamata, Amina Kaboso Shaban, Yoshitaka Tateishi, Kosuke Ito, Sohkichi Matsumoto. Nucleic Acid Res., Volume
52,Issue 2, 25 January 2024, Pages816–830, https://doi.org/10.1093/nar/gkad1149
↑
松本 壮吉、マイコバクテリウム属(抗酸菌)。標準微生物学 第15版。2024年、錫谷 達夫、松本 哲哉 編。医学書院、ISBN-13: 978-4-260-05344-0
総説
松本 壮吉。人の長寿と長生きの抗酸菌; 抗酸菌がゆっくりと生きて頻繁に眠るしくみから、薬剤開発への展開を考える。
第96回日本ハンセン病学会シンポジウム、ミニレビュー、第 92 巻 2 号(2023 年 8 月) P41-46
著書
立石 善隆、松本 壮吉。マイコバクテリウム属細菌(抗酸菌)による疾病とバイオフィルム形成。野村 暢彦 監修、
バイオフィルム革新的制御技術、124-132、NTSinc, 東京、ISBN 978-4-86043-0 C3045, 2023
Microbiol Spectr. 2022 Jun 29;10(3):e0053022. doi: 10.1128/spectrum.
Scientific Reports. 2022 Mar 12;12(1):4310. doi: 10.1038/s41598-022-08228-7.
Direct attachment with erythrocytes augments extracellular growth of pathogenic mycobacteria
2022 Apr 27;10(2):e0245421. doi: 10.1128/spectrum.02454-21.
The FEBS Journal 2022 Feb 24. doi: 10.1111/febs.16412.
The FASEB Journal 2022 Jan;36(1):e22096. doi: 10.1096/fj.202101074RR.
著書
Nishiyama A and Matsumoto S. Bacterial factors regulating M. tuberculosis infection and persistence. Yamamoto S, Maeyama J, and Takii T editors. BCG vaccine and adjuvant, Japan anti-tuberculosis association, Tokyo, 212-229, 2022
Ozeki Y, Niki M and Matsumoto S. Host and bacterial factors that regulate Mycobacterium tuberculosis infection and persistence. Yamamoto S, Maeyama J, and Takii T editors. BCG vaccine and adjuvant, Japan anti-tuberculosis association, Tokyo, 235-240, 2022
Oh S, Libardo MDJ, Azeeza S, Pauly GT, Roma JSO, Sajid A, Tateishi Y, Duncombe C, Goodwin M, Ioerger TR, Wyatt PG, Ray PC, Gray DW, Boshoff HIM, Barry CE 3rd. Structure-activity relationships of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as antitubercular agents.
ACS Infect Dis. 2021 Feb 12;7(2):479-492. doi: 10.1021/acsinfecdis.0c00851. Epub 2021 Jan 6. PMID: 33405882.
The espD full gene as a potential biomarker in active pulmonary tuberculosis.
Mertaniasih NM, Surya Suameitria Dewi DN, Soedarsono S, Kurniati A, Rohman A, Nuha Z, Matsumoto S.
Int J Mycobacteriol. 2021 Oct-Dec;10(4):421-427.
Microbiome in sputum as a potential biomarker of chronicity in pulmonary resistant to rifampicin-tuberculosis and multidrug-resistant-tuberculosis patients.
Wiqoyah N, Mertaniasih NM, Artama WT, Matsumoto S.
Int J Mycobacteriol. 2021 Jul-Sep;10(3):260-267.
Sci Rep. 2021 May 26;11(1):10953.
著書
標準微生物学 第14版(医学書院)2021。神谷 茂 監修、錫谷 達夫 / 松本 哲哉 編集。「マイコバクテリウム属 (抗酸菌)」、松本 壮吉。
竹石 惇樹、松本 壮吉、藤井 雅寛。創薬研究者がこれだけは知っておきたい最新のウイルス学。「BCGのウイルス感染症に対する効果と組換えBCG」 技術情報研協会、東京。534-543、2021
総説
竹石 惇樹、長田 秀和、松本 壮吉。
BCGベクターワクチン設計のサイエンス。医学のあゆみ。279号、No 10、p1041-1046、2021
Adduct formation of delamanid with NAD in mycobacteria
Antimicrob Agents Chemother, Published online March 9, 2020.
Frontiers in Immunology, 29 November 2019
PLOS ONE, August 27, 2021 https://doi.org/10.1371/journal.pone.0256946
Scientific Reports. May29;8(1)8197, 2018
High-density lipoprotein suppresses tumor necrosis factor alpha production by mycobacteria-infected human macrophages.
Scientific Reports, Apr 30;8(1);6736, 2018
Niki M, Yoshiyama T, Miyamoto Y, Okamura M. Niki M, Oinuma K, Kaneko Y, Matsumoto S, Sasaki Y, Ogata H, Goto H, Kudoh S, and Hoshino Y.
Longgitudial evaluation of humoral immunity and bacterial and clinical parameters reveals that antige-specific antibodies suppress inflammatory responses in active tuberculosis.
J Immun Res, 4;2018:4928757, 2018
尾関 百合子、松本 壮吉. 「結核免疫防御機能」、特集;結核・非結核抗酸菌症(医学書院)、66巻、4号、p643-649、2018
松本 壮吉. 「抗酸菌感染症」、バイオフィルム感染症の診断・治療・予防 「臨床と微生物」 45巻、1号、P63-67、2018
松本 壮吉. 「マイコバクテリウム属、アクチノマイセスとノカルジア」「シンプル微生物学 改訂第6版」、小熊 恵二、堀田 博、若宮 伸隆 編.南江堂、東京、196-203、2018
Enany, S., Y. Yoshida, Y. Tateishi, Y. Ozeki, A. Nishiyama, A. Savitskaya, T. Yamaguchi, Y. Ohara, T. Yamamoto, M. Ato, and S. Matsumoto. 2017. Mycobacterial DNA-binding protein 1 is critical for long term survival of Mycobacterium smegmatis and simultaneously coordinates cellular functions. Scientific reports 7: 6810.
Totani, T., Y. Nishiuchi, Y. Tateishi, Y. Yoshida, H. Kitanaka, M. Niki, Y. Kaneko, and S. Matsumoto. 2017. Effects of nutritional and ambient oxygen condition on biofilm formation in Mycobacterium avium subsp. hominissuis via altered glycolipid expression. Scientific reports 7: 41775.
Chadeka, E. A., S. Nagi, T. Sunahara, N. B. Cheruiyot, F. Bahati, Y. Ozeki, M. Inoue, M. Osada-Oka, M. Okabe, Y. Hirayama, M. Changoma, K. Adachi, F. Mwende, M. Kikuchi, R. Nakamura, Y. D. J. Kalenda, S. Kaneko, K. Hirayama, M. Shimada, Y. Ichinose, S. M. Njenga, S. Matsumoto, and S. Hamano. 2017. Spatial distribution and risk factors of Schistosoma haematobium and hookworm infections among schoolchildren in Kwale, Kenya. PLoS Negl Trop Dis 11: e0005872.
松本 壮吉. 結核の潜在化と発症機構 「結核 改訂版」 光山 正雄、鈴木 克洋 編.医薬ジャーナル社、大阪、134-149、2017
Totani, T., Y. Nishiuchi, Y. Tateishi, Y. Yoshida, H. Kitanaka, M. Niki, Y. Kaneko, and S. Matsumoto. 2017. Effects of nutritional and ambient oxygen condition on biofilm formation in Mycobacterium avium subsp. hominissuis via altered glycolipid expression. Sci, Rep 2045-2322 (Electronic).
Takahashi, H., M. Haga, T. Sunagawa, T. Saitoh, T. Kitahara, S. Matsumoto, and M. Ohnishi. 2016. Meningococcal carriage rates in healthy individuals in Japan determined using Loop-Mediated Isothermal Amplification and oral throat wash specimens. Journal of infection and chemotherapy : 22: 501-504.
Niki, M., M. Suzukawa, S. Akashi, H. Nagai, K. Ohta, M. Inoue, M. Niki, Y. Kaneko, K. Morimoto, A. Kurashima, S. Kitada, S. Matsumoto, K. Suzuki, and Y. Hoshino. 2015. Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development. J Immunol Res: aa527395.
Ozeki, Y., M. Igarashi, M. Doe, A. Tamaru, N. Kinoshita, Y. Ogura, T. Iwamoto, R. Sawa, M. Umekita, S. Enany, Y. Nishiuchi, M. Osada-Oka, T. Hayashi, M. Niki, Y. Tateishi, M. Hatano, and S. Matsumoto. 2015. A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Gueren. PLoS One 10: e0141658.
Takahashi, H., M. Haga, T. Sunagawa, T. Saitoh, T. Kitahara, S. Matsumoto, and M. Ohnishi. 2016. Meningococcal carriage rates in healthy individuals in Japan determined using Loop-Mediated Isothermal Amplification and oral throat wash specimens. Journal of infection and chemotherapy. In press
松本 壮吉、西山 晃史、尾関 百合子。結核菌の潜伏感染に関わるメカニズムと新しい結核制御技術の可能性。化学療法の領域。31 巻、9号、p93-100、2015
松本 壮吉、結核菌の増殖制御や潜在性結核の解析および、結核ワクチンの開発研究。臨床と研究 別刷。92巻、p116、2015
立石 善隆、松本 壮吉。結核菌の病原因子。呼吸器内科。29巻、1号、p65-70、2016
Nishiuchi, Y., A. Tamaru, Y. Suzuki, S. Kitada, R. Maekura, Y. Tateishi, M. Niki, H. Ogura, and S. Matsumoto. 2014. Direct detection of Mycobacterium avium in environmental water and scale samples by loop-mediated isothermal amplification. J Water Health 12:211-219.
Nagi, S., E. A. Chadeka, T. Matsumoto, S. and S. Hamano等 2014. Risk Factors and Spatial Distribution of Schistosoma mansoni Infection among Primary School Children in Mbita District, Western Kenya. PLoS Negl Trop Dis 8:e2991.
Fujii, Y., S. Kaneko, S. M. Nzou, S. Matsumoto 等. 2014. Serological surveillance development for tropical infectious diseases using simultaneous microsphere-based multiplex assays and finite mixture models. PLoS Negl Trop Dis 8:e3040.
Ohtsuka, K., H. Ohnishi, E. Nozaki, J. Pais Ramos, E. Tortoli, S. Yonetani, S. Matsushima, Y. Tateishi, S. Matsumoto, and T. Watanabe. 2014. Whole-Genome Sequence of Mycobacterium kyorinense. Genome Announc 2:e01062-01014.
Morimoto, K., T. Ozawa, K. Awazu, N. Ito, N. Honda, S. Matsumoto, and D. Tsuruta. 2014. Photodynamic Therapy Using Systemic Administration of 5-Aminolevulinic Acid and a 410-nm Wavelength Light-Emitting Diode for Methicillin-Resistant Staphylococcus aureus-Infected Ulcers in Mice. PLoS One 9:e105173.
松本 壮吉、尾関 百合子。結核ワクチン開発の現状と新しい結核ワクチン開発に向けて。化学療法の領域。30巻、p127-134, 2014.
西内 由紀子、松本 壮吉。抗酸菌の細菌学的特徴と病原性。感染症内科. 2巻、p8-14, 2014
松本 壮吉。 結核とその制圧を目指した研究。新潟県医師会報. 第766号. P2-7, 2014
西山 晃史、松本 壮吉。病原微生物学、荒川 宣親、神谷 茂、柳 雄介 監修、抗酸菌と放線菌。東京化学同人、東京。120-129、2014
Osada-Oka, M., Y. Tateishi, Y. Hirayama, Y. Ozeki, M. Niki, S. Kitada, R. Maekura, K. Tsujimura, Y. Koide, N. Ohara, T. Yamamoto, K. Kobayashi, and S. Matsumoto. 2013. Antigen 85A and mycobacterial DNA-binding protein 1 are targets of immunoglobulin G in individuals with past tuberculosis. Microbiol Immunol 57:30-37.
Tateishi, Y., A. Tamaru, Y. Ogura, M. Niki, T. Wada, T. Yamamoto, K. Hirata, T. Hayashi, and S. Matsumoto. 2013. Whole-Genome Sequence of the Potentially Hypertransmissible Multidrug-Resistant Mycobacterium tuberculosis Beijing Strain OM-V02_005. Genome Announc 1.
amashita, Y., Y. Hoshino, M. Oka, S. Matsumoto, H. Ariga, H. Nagai, M. Makino, K. Ariyoshi, and Y. Tsunetsugu-Yokota. 2013. Multicolor Flow Cytometric Analyses of CD4(+) T Cell Responses to Mycobacterium tuberculosis-Related Latent Antigens. Jpn J Infect Dis 66:207-215.
Taniguchi, K., T. Takii, S. Yamamoto, J. Maeyama, S. Iho, M. Maruyama, N. Iizuka, Y. Ozeki, S. Matsumoto, T. Hasegawa, Y. Miyatake, S. Itoh, and K. Onozaki. 2013. Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG. Immun Ageing 10:25.
Fukuda, T., T. Matsumura, M. Ato, M. Hamasaki, Y. Nishiuchi, Y. Murakami, Y. Maeda, T. Yoshimori, S. Matsumoto, K. Kobayashi, T. Kinoshita, and Y. S. Morita. 2013. Critical roles for lipomannan and lipoarabinomannan in cell wall integrity of mycobacteria and pathogenesis of tuberculosis. MBio 4:e00472-00412.
松本 壮吉。潜在性結核と結核菌の潜伏感染メカニズム. 医学のあゆみ 246, p470-473, 2013.
松本 壮吉。抗酸菌の休眠現象や薬剤抵抗性に関わる分子メカニズム. Jpn. J. Lepr., 82, p119-122, 2013.
仁木 満美子、松本 壮吉、鉄代謝およびイソニアジド耐性にかかわる結核菌分子の機能と治療法開発の可能性。化学療法の領域、Vol29 2号、p119-124.2013.
Niki, M., M. Niki, Y. Tateishi, Y. Ozeki, T. Kirikae, A. Lewin, Y. Inoue, M. Matsumoto, J. L. Dahl, H. Ogura, K. Kobayashi, and S. Matsumoto. 2012. A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria. J Biol Chem 287:27743-27752.
ateishi, Y., S. Kitada, K. Miki, R. Maekura, Y. Ogura, Y. Ozeki, Y. Nishiuchi, M. Niki, T. Hayashi, K. Hirata, K. Kobayashi, and S. Matsumoto. 2012. Whole-Genome Sequence of the Hypervirulent Clinical Strain Mycobacterium intracellulare M.i.198. J Bacteriol 194:6336.
Tamaru, A., C. Nakajima, T. Wada, Y. Wang, M. Inoue, R. Kawahara, R. Maekura, Y. Ozeki, H. Ogura, K. Kobayashi, Y. Suzuki, and S. Matsumoto. 2012. Dominant Incidence of Multidrug and Extensively Drug-Resistant Specific Mycobacterium tuberculosis Clones in Osaka Prefecture, Japan. PLoS One 7:e42505.
Fujii, J., M. Naito, T. Yutsudo, S. Matsumoto, D. P. Heatherly, T. Yamada, H. Kobayashi, S. Yoshida, and T. Obrig. 2012. Protection by a Recombinant Mycobacterium bovis Bacillus Calmette-Guerin Vaccine Expressing Shiga Toxin 2 B Subunit against Shiga Toxin-Producing Escherichia coli in Mice. Clin Vaccine Immunol 19:1932-1937.
松本 壮吉、結核菌の増殖、長期生存、および静止期以降の薬剤抵抗性獲得の分子メカニズム、Bacterial Adherence & Biofilm、Vol. 26, p21-24,
新潟大学医学部細菌学教室 〒951-8510 新潟県新潟市中央区旭町通一番町757 新潟大学医学部西研究棟内
Copyright © Department of Bacteriology, Niigata University Graduate School of Medicine All Rights Reserved.